Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05404958
Other study ID # STUDY00014745
Secondary ID GRANT13455302
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date March 31, 2027

Study information

Verified date March 2024
Source University of Washington
Contact McKenna Eastment
Phone 206-4165074
Email mceast@uw.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

East and Southern Africa is home to 6.2% of the world's population but includes 54% of all people living with HIV (PLWH). In this region, three out of five PLWH are women, and there is a particularly high burden of HIV amongst adolescent girls and young women (AGYW). Over half of African women use family planning (FP) services. Integration of HIV prevention and treatment with FP services holds promise for supporting progress toward the UNAIDS 95-95-95 targets for testing, treatment, and prevention. Nonetheless, integration of even basic HIV prevention and treatment services into FP clinics remains low and how best to integrate these services is still unknown. In a previous trial, the Systems Analysis and Improvement Approach (SAIA), was an effective implementation strategy for improving HIV counseling and testing in a small selection of FP clinics in Mombasa County, Kenya when delivered by research staff. SAIA incorporates a cascade analysis tool, sequential process flow mapping, and cycles of micro-intervention development, implementation, and assessment to improve a care cascade. More data is needed to understand if SAIA is effective for also improving linkage to HIV care and screening and linkage to pre-exposure prophylaxis (PrEP) in FP clinics when SAIA is delivered at scale by Kenyan public health workforce. The first objective of this study is to conduct a cluster-randomized trial evaluating the effectiveness of SAIA versus control (usual procedures with no specific intervention) for increasing HIV counseling, testing, linkage to HIV care, and screening and linkage to PrEP in new FP clients and new and returning AGYW clients. There will be a particular focus on the HIV prevention and treatment of AGYW in this study and any AGYW presenting for FP care will be prioritized. Quantitative and qualitative data will be analyzed using the RE-AIM framework to evaluate the program's Reach, Effectiveness, Adoption, Implementation, and Maintenance. To understand how SAIA could be integrated into national Ministry of Health policies and programs, activity-based costing will be conducted to estimate the budget and program impacts of SAIA, scaled to a County level, from a Ministry of Health perspective. It is hypothesized that compared to control, SAIA will be effective at increasing HIV counseling, HIV testing, linkage to HIV care, and screening and linkage to PrEP for new FP clients and all new and returning AGYW FP clients when delivered at scale by Kenyan public health staff. The implementation evaluation, costing, and budget impact analysis will establish a road map for national-level implementation, positioning Kenya as a global leader in integrating FP/HIV services.


Description:

AIM 1: To conduct a cluster-randomized trial evaluating the effectiveness of SAIA versus control (usual procedures) for increasing HIV counseling, testing, linkage to care, and screening and linkage to PrEP in new FP clients and new and returning AGYW clients. Quantitative and qualitative data will be analyzed using the RE-AIM framework (21). 1a) Reach: Proportion of intervention arm health facility clients' reached with the intervention 1b) Effectiveness: Compare the effectiveness of SAIA vs. control for increasing rates of HIV counseling, testing, linkage to care, and screening and linkage to PrEP in new FP clients and new and returning AGYW clients 1c) Adoption: Proportion of clinics adopting SAIA; adoption determinants identified using the Implementation Research Logic Model (IRLM) (22) and Organizational Readiness for Implementing Change (ORIC) scale (23) 1d) Implementation: Proportion of FP clinics implementing SAIA with high fidelity at 12 months and at 24 months; barriers and facilitators of implementation at scale by County DOH personnel will be explored using constructs from the Consolidated Framework for Implementation Research (CFIR) and the IRLM (24) 1e) Maintenance: Proportion of FP clinics maintaining SAIA at 12 months and 24 months after introduction AIM 2: To estimate the incremental cost and budget and program impacts of SAIA from a County DOH perspective. We will conduct activity-based costing and develop budget impact scenarios based on SAIA's adoption.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date March 31, 2027
Est. primary completion date June 28, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: FP clinics: -All FP clinics that receive County-supplied FP products will be eligible to participate. FP clinic managers and staff: -Any FP clinic manager that is 18 years and older is eligible to be interviewed. -These clinic managers can be male or female. Kenyan public health staff: - Any Kenyan public health staff that is 18 years and older is eligible to be interviewed. - These public health staff can be male or female. Exclusion Criteria: FP clinics: - Any clinics that are expected to close within the next year at the time of study initiation - 12 facilities that participated as SAIA intervention facilities in our small-scale trial where the intervention was led by research staff. FP clinic managers and staff: No exclusion criteria Kenyan public health staff: No exclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Systems Analysis and Improvement Approach (SAIA)
What is SAIA? It is a 5-step cycle that is repeated every 4-6 weeks for continuous quality improvement, implemented by Kenyan public health workforce and FP clinic staff, and monitored by Mombasa DOH. Step 1: Understanding the cascade from FP clinic enrollment to HIV testing to linkage to treatment and prevention services. Step 2: Use process mapping to identify modifiable bottlenecks. Step 3: Define and implement workflow adaptations to eliminate modifiable bottlenecks. Step 4: Monitor change in performance. Step 5: Repeat the analysis and improvement cycle (steps 1-4).

Locations

Country Name City State
Kenya FP Clinics in Mombasa County Mombasa

Sponsors (2)

Lead Sponsor Collaborator
University of Washington Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reach HIV counseling Proportion of FP clients in intervention clinics counseled for HIV out of the total FP clients seen in the clinic Months 1-12
Primary Effectiveness HIV counseling Proportion of FP clients (counseled for HIV out of the total FP clients seen in the clinic in intervention vs control clinics Months 1-12
Primary Reach HIV testing Proportion of FP clients in intervention clinics counseled for HIV out of the total FP clients seen in the clinic Months 1-12
Primary Effectiveness HIV testing Proportion of FP clients tested for HIV out of the total FP clients who should be tested in intervention vs control clinics Months 1-12
Primary Reach Linked to HIV care Proportion of HIV seropositive FP clients who are out of care linked to comprehensive HIV care in intervention clinics out of all HIV seropositive FP clients who are out of care Months 1-12
Primary Effectiveness Linked to HIV care Proportion of HIV-seropositive FP clients who are out of care then linked to comprehensive HIV care out of all HIV-seropositive FP clients who are out of care in intervention vs control clinics Months 1-12
Primary Reach Screening and linkage to PrEP Proportion of HIV seronegative FP clients in intervention clinics screened for PrEP out of all HIV seronegative FP clients
Proportion of HIV seronegative FP clients eligible for PrEP in intervention clinics who are linked to PrEP out of all HIV seronegative FP clients eligible for PrEP
Months 1-12
Primary Effectiveness Screening and linkage to PrEP 1. Proportion of HIV-seronegative FP clients screened for PrEP out of all HIV-seronegative FP clients in intervention vs control clinics 2. Proportion of HIV-seronegative FP clients who are eligible for PrEP who are linked to PrEP out of all HIV-seronegative FP clients who are eligible for PrEP in intervention vs control clinics 2. Proportion of HIV seronegative FP clients eligible for PrEP in intervention clinics who are linked to PrEP out of all HIV seronegative FP clients eligible for PrEP Months 1-12
Primary Adoption 1. Proportion of intervention clinics that participated in the initial training and selected their first micro-intervention 12 months
Primary Adoption 2. In-depth interviews using the IRLM and CFIR; Administer survey using the ORIC assessment 12 months
Primary Implementation 1a. Proportion of intervention clinics implementing SAIA with high fidelity
1b. Proportion of intervention clinics implementing SAIA with low fidelity
12 months
Primary Implementation 1a. Proportion of intervention clinics implementing SAIA with high fidelity
1b. Proportion of intervention clinics implementing SAIA with low fidelity
24 months
Primary Implementation 2. In-depth interviews with FP clinic staff in intervention clinics and county and national personnel using IRLM and CFIR. 12 months and 24 months
Primary Maintenance 1a. Proportion of FP clinics with sustained maintenance
1b. Proportion of FP clinics with partial maintenance
12 & 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2